These studies use the innate histidine-rich composition of HRP2 and artificially histidine-enriched antibodies to concentrate malaria biomarkers from large volume blood samples for detection on lateral flow assays (LFAs), the most commonly used malaria RDT. This evidence concerns the gene HDGFL2 and malaria.